Rare diseases
Investigational molecules
Locations
Back to Latvia45 clinical trials in Liepaja, Latvia. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in LatviaKliniskiePetijumi.lv(opens in a new tab)Study of inclisiran to prevent heart attacks and strokes in people with atherosclerotic cardiovascular disease
LatviaStudy on the Effect of Obicetrapib in Patients with Atherosclerotic Cardiovascular Disease Not Adequately Managed by Current Lipid-Lowering Treatments
LatviaStudy on the Effects of MORF-057 for Adults with Moderate to Severe Ulcerative Colitis
LatviaStudy Comparing Upadacitinib, Placebo, and Adalimumab for Patients with Moderate to Severe Rheumatoid Arthritis on Stable Methotrexate Treatment
LatviaStudy on Inclisiran for Preventing Heart Disease in High-Risk Patients
LatviaComparison of SRSD107 and enoxaparin to prevent blood clots in adults undergoing knee replacement surgery
LatviaComparison of Risankizumab and Vedolizumab for Treatment of Moderate to Severe Ulcerative Colitis in Adults Who Have Not Received Targeted Therapies
LatviaStudy on UGN-102 (Mitomycin) for Treating Low Grade Non-Muscle Invasive Bladder Cancer in Patients at Intermediate Risk of Recurrence
LatviaStudy of single-dose oritavancin safety and tolerability in children with acute bacterial skin and skin structure infections
LatviaStudy Comparing Abelacimab and Apixaban for Preventing Blood Clots in Cancer Patients
LatviaStudy on Abelacimab and Dalteparin for Preventing Blood Clots in Patients with Gastrointestinal or Genitourinary Cancer
LatviaStudy on the Safety and Effectiveness of Naronapride for Adults with Moderate Idiopathic or Diabetic Gastroparesis
LatviaThe busiest research cities in the country
What the registry says about research in the country
Clinical trials focusing on treatments for psoriatic arthritis, ulcerative colitis, and systemic lupus erythematosus. Studies evaluate novel therapies including zasocitinib, eltrekibart, and upadacitinib for improved disease management.
Research aims to enhance treatment efficacy and patient outcomes in chronic inflammatory conditions.
Innovative studies targeting atherosclerotic cardiovascular disease and stroke prevention. Trials examine new medications like inclisiran and asundexian for managing cardiovascular risks and preventing major adverse events.
Focus on reducing cardiovascular events and improving patient outcomes in high-risk populations.
Research investigating treatments for bladder cancer and prostate cancer. Clinical trials evaluate innovative therapies including UGN-102 and novel combinations for various stages of cancer progression.
Studies aim to improve treatment options and outcomes for cancer patients.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
